Quick Answer
Universe Pharmaceuticals INC reported Stockholders Equity of $56.13 billion for fiscal year 2025.
Universe Pharmaceuticals INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $56.13B | +23.4% |
| 2024 | $45.50B | +62.7% |
| 2023 | $27.97B | -20.8% |
| 2022 | $35.33B | +75083.6% |
| 2021 | $46.99M | +125.9% |
| 2020 | $20.80M | +68.0% |
| 2019 | $12.38M | +27.9% |
| 2018 | $9.68M | — |
- Universe Pharmaceuticals INC showed an increase of +23.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Universe Pharmaceuticals INC’s stockholders equity has grown by 579656.2% (from $9.68 million to $56.13 billion).
- The most recent figure is from Universe Pharmaceuticals INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: